Technical Analysis for NCNA - NuCana plc

Grade Last Price % Change Price Change
grade F 6.8 2.26% 0.15
NCNA closed up 2.26 percent on Friday, October 18, 2019, on 82 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical NCNA trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.26%
Inside Day Range Contraction 2.26%
Wide Bands Range Expansion 2.26%
20 DMA Resistance Bearish 8.11%
MACD Bullish Signal Line Cross Bullish 8.11%
Inside Day Range Contraction 8.11%
Wide Bands Range Expansion 8.11%

Older signals for NCNA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NuCana PLC is a clinical-stage biopharmaceutical company. The Company is focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The Company utilizes its ProTide technology to develop medicines to overcome cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline of products includes Acelarin, NUC-3373 and NUC-7738. Acelarin is a nucleotide analog and is a ProTide transformation of gemcitabine for the treatment of cancer. The Company is evaluating Acelarin in four clinical trials across several solid tumor indications. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil for the treatment of a wide range of cancers. NUC-3373 is in a Phase I trial for the potential treatment of a wide range of solid tumor cancers. NUC-7738 is a ProTide transformation of cordycepin, a novel nucleoside analog.
Is NCNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.48
52 Week Low 4.01
Average Volume 108,021
200-Day Moving Average 11.6667
50-Day Moving Average 7.8332
20-Day Moving Average 6.6625
10-Day Moving Average 6.313
Average True Range 0.7381
ADX 20.11
+DI 24.1323
-DI 14.7748
Chandelier Exit (Long, 3 ATRs ) 6.0107
Chandelier Exit (Short, 3 ATRs ) 8.0143
Upper Bollinger Band 7.6934
Lower Bollinger Band 5.6316
Percent B (%b) 0.57
BandWidth 30.946341
MACD Line -0.4641
MACD Signal Line -0.5631
MACD Histogram 0.099
Fundamentals Value
Market Cap 216.32 Million
Num Shares 31.8 Million
EPS -0.40
Price-to-Earnings (P/E) Ratio -17.00
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.76
Resistance 3 (R3) 7.77 7.45 7.60
Resistance 2 (R2) 7.45 7.21 7.45 7.55
Resistance 1 (R1) 7.13 7.06 6.97 7.12 7.49
Pivot Point 6.81 6.81 6.74 6.81 6.81
Support 1 (S1) 6.49 6.57 6.33 6.48 6.11
Support 2 (S2) 6.17 6.42 6.17 6.05
Support 3 (S3) 5.85 6.17 6.00
Support 4 (S4) 5.84